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Mrc1 (Mediator of Replication Checkpoint 1) is a component of the DNA replication fork
machinery and is necessary for checkpoint activation after replication stress. In this study,
we addressed the role of Mrc1 at uncapped telomeres. Our experiments show that Mrc1
contributes to the vitality of both cdc13-1 and yku70 telomere capping mutants. Cells with
telomere capping defects containing MRC1 or mrc1AQ, a checkpoint defective allele, exhibit
similar growth, suggesting growthdefects of cdc13-1mrc1 arenot due to checkpoint defects.
This is in accordance with Mrc1-independent Rad53 activation after telomere uncapping.
Poor growth of cdc13-1mutants in the absence ofMrc1 is a result of enhanced single stranded
DNA accumulation at uncapped telomeres. Consistent with this, deletion of EXO1, encodingMrc1
Telomere
ssDNA
CDC13
YKU70
E
a nuclease that contributes to single stranded DNA accumulation after telomere uncapping,
improves growthof cdc13-1mrc1 strains anddecreases ssDNAproduction.Our observations
show thatMrc1, a core component of the replication fork, plays an important role in telomere
capping, protecting from nucleases and checkpoint pathways.
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. Introduction
elomeres are specialized DNA–protein complexes at the
nd of eukaryotic chromosomes. Proper telomere structure
s essential for chromosome integrity and genome stability
ecause telomeres protect natural chromosome ends from
egradation and end-to-end fusion and because they ensure
omplete genome replication. Telomeres differ from Double
trand Breaks (DSBs) in that they normally fail to activate
NA repair or DNA damage checkpoint pathways. If that
as the case, then they would undergo recombination and
hromosomal fusions and dicentric chromosomes would be
enerated [1–4].
Many proteins associate with telomeric DNA. These pro-
eins ensure that telomeres behave differently from DSB ends
nd help maintain chromosomal stability. Some telomeric
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proteins bind speciﬁcally to dsDNA and others show higher
afﬁnity to ssDNA. In budding yeast, there are numerous pro-
teins with afﬁnity for telomeric dsDNA, such as Rap1, Sir2,
Sir3, Sir4, Rif1 and Yku70/Yku80 [5]. The budding yeast telom-
eric ssDNA ends are thought to be protected by three essential
proteins, Cdc13, Stn1 and Ten1 [6–11].
If telomeres become uncapped, they activate a DNA dam-
age response pathway leading to cell cycle arrest [12–14].
Moreover, recently it has been suggested that telomeres trig-
ger a transient DNA damage response in each S phase in
order to complete DNA replication and cap chromosome ends
[15]. DNA damage response pathways are complex networks
Open access under CC BY license.ators facilitate the transmission of the DNA damage signal
from sensors to downstream effectors; activation of the lat-
ter affecting cell cycle progression [16]. Mrc1 (Mediator of
( 2 01608 dna repa ir 6
Replication Checkpoint 1) appears to take themediator role in
Rad53 activation under replication stress [17]. However, paral-
lel pathways exist because inmrc1mutants Rad53 activation
occurs through Rad9 (another mediator protein), presum-
ably because the accumulation of “DNA damage” rather than
“replication defects” in mrc1 mutants leads to activation of
Rad9 and thereby activation of Rad53 [17].
Mrc1 also appears to be directly involved in DNA replica-
tion and, because of this, mrc1 cells display a slow S phase
[18]. Mrc1 is an active component of the replication machin-
ery, loaded onto DNA shortly after replication initiates, and
moving with other components of replication forks [19–21]. In
the presence of hydroxyurea, a type of replication stress, Mrc1
appears to forma stable replication-pausing complex prevent-
ing the uncoupling of the replication machinery from DNA
synthesis [20–22]. According to this model, Mrc1 mediates
activation of Rad53 under conditions of replication stress so
that subsequent DNA repair events occur and cell replication
resumes normal function [22]. However, recent experiments
suggest that the role of Mrc1 at stalled replication forks is
more than activating Rad53, since mrc1AQ cells, defective in
Rad53 activation, are not defective in replication fork initi-
ation or progression [18,20,21]. mrc1AQ is a mutant allele in
which SQ/TQ residues have been substituted with AQ, result-
ing in its inability to mediate phosphorylation and activation
of Rad53 [18].
Although Mrc1 is involved in the DNA replication check-
point, it has been shown that it is not required for the
DNA damage checkpoint, since cdc13-1 mrc1 double mutants
arrest in G2 at non-permissive temperatures [17]. It has been
reported that activation of Rad53 in response to telomere
shortening still occurs in the absence of Rad9 and that Mrc1
is responsible for this activation in telomerase-deﬁcient cells,
in which telomeres continually shorten until they activate
a checkpoint [23]. Surprisingly, though, tlc1 mrc1 dou-
ble mutants arrest cell division, suggesting that Mrc1 is not
required for cell cycle arrest in telomerase negative cells. In
contrast, after cdc13-1 induced telomere uncapping, Rad53
activation is entirely Rad9-dependent and Mrc1-independent
[23].
Here we investigated the role of Mrc1 at uncapped telom-
eres, using the temperature sensitive cdc13-1 and yku70
mutations to uncap telomeres. Our experiments indicate that
Mrc1 protects telomeres from the DNA damage response and
that the role of Mrc1 in DNA replication forks, rather than in
checkpoint activation, is important for protection of telom-
eres.
2. Materials and methods
2.1. Yeast strains and plasmids
All strains in theW303 background are RAD5 and they contain
an ade2-1 mutation (Supplemental Table 1); therefore yeast
extract/peptone/dextrose (YEPD)was supplementedwith ade-
nine at 50mg/l. Strains 3393–3402 are in the S288C background
(Supplemental Table 1) and they were generated by mating a
single gene deletion mutant array [24] with a cdc13-1 query
strain [25]. To construct strains, standard genetic procedures0 7 ) 1607–1617
of transformation and tetrad analysis were used [26]. pMRC1
and pmrc1AQ, also carrying the URA3 gene were a gift from
Steven Elledge [17,18].
MRC1was disrupted in two differentways. Firstly, theMRC1
ORF was substituted with KanMX6, with a PCR based method
[27]. Primers 5′-tcgttattcgcttttgaacttatcaccaaatattttagtgCGGA-
TCCCCGGGTTAATTAA-3′ (#878) and 5′-ctggagttcaatcaacttc-
ttcggaaaagataaaaaaccaGAATTCGAGCTCGTTTAAAC-3′ (#881),
which contain homology to upstream and downstream
sequences of MRC1 (bases in lowercase), were used to
amplify a 1559bp KanMX6 sequence (pFA6a-kanMX6; [27]).
The PCR product was transformed into yeast and candi-
date colonies were selected for G418 resistance. Integration
of the KanMX6 marker into the MRC1 locus was con-
ﬁrmed by PCR, using two sets of primers: (i) forward
5′-CCAAGAACAGACAAACAACTAAGGA-3′ (#876) with reverse
primer 5′-TCAGCATCCATGTTGGAATT-3′ (#81) and (ii) for-
ward 5′-CCATCCTATGGAACTGCCTC-3′(#82) with reverse 5′-
CCTAGACTCGGGTGCCATCT-3′ (#880). Disruption of MRC1 was
also conﬁrmed by Southern blot (data not shown). Alterna-
tively, MRC1 was substituted with URA3 using a restriction
enzyme digest approach. First, pMRC1was digested with XhoI
and a 5008bp fragment containing the full MRC1 gene was
cloned into XhoI digested pIC19H vector (2.7 kb) to create
pAT1065. A correct clone was identiﬁed by restriction digests.
pAT1065 was digested with SpeI to remove a 2.31kb DNA frag-
ment containing the bulk of MRC1, which was replaced with
a 1.3 kb BamHI URA3 gene fragment from pDL349 (pBSB+KS
containing a BamHI fragment containing the URA3 gene)
by blunt cloning following treatment with DNA polymerase
I Large (Klenow) fragment (New England Biolabs). Positive
clones were selected by restriction enzyme digests to iden-
tify the disruption of the bulk of MRC1 with URA3 (pAT1066).
Disruption ofMRC1was also conﬁrmed by Southern blot (data
not shown). To disruptMRC1, pAT1066 was digested with XhoI
prior to transformation of yeast.
2.2. Spot tests
Single colonies were inoculated into 2ml YEPDextrose (YEPD)
and incubated overnight, with aeration, at 23 ◦C. The follow-
ing day, 200l of each culture was inoculated into 2ml of fresh
YEPD and returned to 23 ◦C. Cells were grown for three more
hours, and cell numbers were determined in a haemocytome-
ter. The cells were then centrifuged (13,000 rpm for 10 s in a
microcentrifuge), washed twice with sterile water and resus-
pended in water to a ﬁnal concentration of 1.5×107 cells/ml.
A ﬁve-fold dilution series of each of the cultures was pre-
pared using sterile water in a 96 well plate and 3–5l spotted
onto plates using a 48-prong replica plating device. Plateswere
incubated at various temperatures for 2–3 days before being
photographed. For spot tests with strains containing pMRC1,
pmrc1AQ or pRS416 the steps were as described above, but
strains were grown on selective medium (-URA). All strains
shown as if on a single agar plate were grown on the same
plate, although in some cases their positions were moved
using Adobe Photoshop and Adobe Illustrator CS. Unless oth-
erwise stated, at least two different strains of the same
genotype were spot tested and representative examples are
shown.
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.3. Yeast transformation
igh efﬁciency transformations needed for gene disruptions
ere performed according to Gietz et al. [28]. For plasmid
ransformations a more rapid method was used [29].
.4. Western blots
rotein extracts were prepared by glass bead breakage in
CA, essentially as previously described [30,31]. Bio-Rad gels
7.5% Tris–HCl), Schleicher and Schuell Protan Nitrocellulose
embranes and the Pierce Supersignal West Pico Chemilu-
inescent Substrate detection kit were used in a standard
estern blot procedure. Rabbit anti-Rad53 polyclonal anti-
ody (AbDL50, 1:1000 dilution, a gift from Dan Durocher
32]) was a primary antibody used with an anti-rabbit-HRP
AbDL7, 1:10,000 dilution, Dako P0448) as a secondary anti-
ody used.Mouse anti-tubulin (TAT-1, AbDL42, 1:2000 dilution,
gift from Keith Gull [33] and anti-mouse-HRP (AbDL6,
:10,000 dilution, Dako P0447) were used for tubulin loading
ontrols.
.5. Telomere length measurement by Southern blot
trains were grown to saturation in liquid YEPD at 23 ◦C. DNA
rom each strain was subjected to XhoI cut. The digested
NA was loaded on a 0.8% agarose gel, run at low voltage
vernight, transferred to a Magna nylon membrane and UV
ross-linked. The membrane was then hybridised with a Y′-
G probe [34]. A non-radioactive detection kit was used for the
etection of the hybridisation (Amersham, Arlington Heights,
L).
.6. Synchronous cultures
dc13-1 cdc15-2 bar1 strains with additional mutations (see
upplemental Table 1) were grown in YEPD at 23 ◦C overnight.
n the morning, cells were adjusted to a concentration of
×106 buds/ml in 250ml. Cultures were grown for three more
ours, then arrested with 20nM -factor for a further 2.5h.
he cultures were then released from G1 arrest by centrifu-
ation and washed twice in YEPD and placed at 36 ◦C, 40min
fter the culture was ﬁrst centrifuged. Cell cycle position was
onitored as previously described [13]. DNAwas prepared and
he fraction of single stranded DNA (ssDNA) was measured as
reviously described [35].
.7. Asynchronous cultures
dc13-1 strains with additional mutations indicated were
rown in YEPD at 23 ◦C overnight. In the morning, cells were
djusted to a concentration of 1×107 cells/ml and tempera-
ure was raised to 27.3 ◦C. Every 90min samples were taken
or cell cycle position and cell density was re-adjusted to
×107 cells/ml. Cell numberswere determinedwith a haemo-
ytometer. Samples for Western blots were collected from
xponentially growing cultures 2h after the temperature was
aised from 23 ◦C to 36 ◦C.) 1607–1617 1609
2.8. Cell cycle position determination
A 1ml sample of culture was centrifuged for 8–10 s at high
speed, the supernatant was aspirated, and cells were ﬁxed
at 70% ethanol overnight. The ﬁxed cells were washed
twice in water before being resuspended in 4,6-diamidino-
2-phenylindole (DAPI, 0.2g/ml). Cell cycle distribution was
monitored by DAPI staining of nuclei and ﬂuorescence
microscopy. For DAPI staining, 100 cells for each sample were
counted and classiﬁed as: (1) unbudded, single DAPI-stained
body; (2) small budded, single DAPI-stained body, with the bud
<50% of the diameter of the mother cell; (3) medial nuclear
division, single DAPI-stained body, with bud >50% diameter
of mother cell, the cdc13-1 arrest point; (4) late nuclear divi-
sion, two buds, and twoDAPI-stained bodies, the cdc15-2 arrest
point [36].
3. Results
3.1. Mrc1 contributes to the vitality of cdc13-1 and
yku70 mutants
Since Mrc1 plays a role in the checkpoint response to stalled
replication, we wondered if it also plays a role at uncapped
telomeres. The temperature sensitive cdc13-1mutation causes
a defect in Cdc13, a telomere binding protein, and cells con-
taining this mutation accumulate large amounts of ssDNA at
telomeres atnon-permissive temperatures [12,37,38]. Interest-
ingly, deletion of checkpoint proteins, like Chk1, Mec1, Mec3,
Rad9, Rad17, Rad24 and Rad53 improves growth of cdc13-1
strains at semi-permissive temperatures [39–41]. This is pre-
sumably because checkpoint pathways inhibit cell division
by responding to low levels of ssDNA that accumulates at
telomeres at semi-permissive temperatures. Deletion of other
checkpoint proteins, like the MRX complex, which appears to
play a role in telomere capping, worsens the growth of cdc13-
1 strains [42]. Therefore, we wanted to investigate whether
Mrc1 plays a role at uncapped telomeres and, if so, whether it
behaved like Rad9 orMRX. Fig. 1A shows that deletion ofMRC1
dramatically reduces the growth of cdc13-1 mutant strains at
25 ◦C. The effect of Mrc1 is not as profound as that of the
MRX complex, as cdc13-1 mre11 and cdc13-1 rad50 display
more severe growth defects than cdc13-1 mrc1 even at 23 ◦C
(Supplementary Fig. 1). Thus, Mrc1, like MRX, but unlike the
majority of checkpoint proteins, contributes to the vitality of
cdc13-1 strains.
We next wanted to investigate whether analogous growth
defects of cdc13-1 mrc1 strains occur in yku70 strains.
Yku70 is a telomere capping protein which is also involved
in dsDNA damage repair and in Non-Homologous End Joining
(reviewed in Ref. [43]). Deletion of YKU70 results in a tempera-
ture sensitive phenotype at 37 ◦C, due to telomere uncapping,
which activates a Chk1-dependent cell cycle arrest [36]. Fig. 1B
demonstrates that deletion ofMRC1 results in a severe growth
defect of yku70mutant strains at 35 ◦C and 36 ◦C. Thus, Mrc1
contributes to the vitality of yku70 strains. We conclude that
Mrc1 contributes to the vitality of two cell types defective in
telomere capping.
1610 dna repa ir 6 ( 2 0 0 7 ) 1607–1617
Fig. 1 – Mrc1 contributes to the vitality of cdc13-1 and yku70mutants. Small aliquots of ﬁve-fold dilution series of the
strains indicated, and growing at 23 ◦C, were transferred to plates and incubated at the temperatures shown for 3 days
cated
u70before being photographed. The relevant genotypes are indi
(A) Growth of W303 cdc13-1 mutants. (B) Growth of W303 yk
Mrc1, Tof1 and Csm3 are three proteins that play similar,
although distinct roles in DNA replication [19–21,44]. There-
fore, we wished to address whether Tof1 and Csm3, like Mrc1,
contributed to the vitality of cdc13-1 mutants. Spot test analy-
sis showed that althoughdeletion ofTOF1 orCSM3 also confers
some growth defects on cdc13-1 mutants, deletion of MRC1
has a stronger phenotype (Fig. 1C). Therefore, we decided
to focus on understanding the role of MRC1 at uncapped
telomeres.
3.2. Growth defects of cdc13-1 mrc1 cells are not due
to checkpoint defects
In budding yeast, two independent roles have been previously
reported for Mrc1. One role implicates Mrc1 as a media-
tor of checkpoint activation under replication stress and the
other role is as part of the replication machinery [17–21].
Therefore, we investigated whether the heightened temper-
ature sensitivity phenotype of cdc13-1 mrc1 mutant strains
is a result of a replication defect, a checkpoint defect or
both.
cdc13-1 mrc1 mutants were complemented with either
wild type pMRC1, pmrc1AQ or an empty vector (pRS416) and
strains were grown at various temperatures. Fig. 2 shows that
at 26.2 ◦C, complementation of mrc1 cdc13-1 mutant strains,
with either pMRC1 or pmrc1AQ allele improves growth com-
pared to the empty vector control (compare rows 1–3). Thus,
we conclude that the checkpoint role of Mrc1 is not important
for the vitality of cdc13-1 strains.
At higher temperature we noticed an increased growth of
cdc13-1 mrc1 cells carrying the mrc1AQ allele, compared to
pMRC1. However, this phenotype was observed even in theon the left, and strain numbers are shown in parentheses.
mutants. (C) Growth of S288C cdc13-1 mutants.
presence of the wild type MRC1 allele, suggesting that this
effect is due to some type of dominant effect of mrc1AQ (Fig. 2,
compare rows 2 and 11).
3.3. Exo1 inhibits growth of cdc13-1 mrc1 and
yku70 mrc1 mutants
EXO1 encodes a nuclease known to contribute to ssDNA pro-
duction at uncapped telomeres of cdc13-1 and yku70 strains
[36,39]. If Exo1-dependent ssDNA production at uncapped
telomeres is responsible for the poor growth of cdc13-1 mrc1
and yku70 mrc1mutants, then removing Exo1 should sup-
press their poor growth. Fig. 3A demonstrates that at 25 ◦C,
cdc13-1 mrc1 exo1 triple mutants exhibit better growth
than cdc13-1 mrc1 strains, showing that Exo1 contributes to
the growth defects observed in cdc13-1 mrc1 strains. Impor-
tantly, deleting EXO1 also reverses the growth defect of mrc1
yku70 mutants (Fig. 3B). These data suggest that Mrc1 pro-
tects uncapped telomeres from Exo1.
3.4. Effects of checkpoint mutations on cdc13-1 mrc1
and yku70 mrc1 growth
To understand if checkpoint pathways are activated in mrc1
strains after telomere uncapping, we wanted to combine
cdc13-1 mrc1 and yku70 mrc1 strains with checkpoint
mutations. A genetic screen has revealed that mrc1 is syn-
thetically lethal with rad9, rad17 or rad24 checkpoint
mutations [24]. Consistent with these results we were unable
to recover viable offspring carrying mrc1 in combinations of
any of these checkpoint genes (data not shown). However, we
were able to combine mrc1 with rad53 and chk1, encod-
dna repa ir 6 ( 2 0 0 7 ) 1607–1617 1611
Fig. 2 – The checkpoint role of Mrc1 is not important for the vitality of cdc13-1 strains. Small aliquots of ﬁve-fold dilution
series of the strains indicated, and growing at 23 ◦C, were transferred to plates and incubated at the temperatures shown for
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ng two downstream checkpoint kinases (analogues of human
hk2 and Chk1, respectively).
When cdc13-1 mutants grow at non-permissive temper-
tures Rad53 and Chk1 dependent parallel pathways are
ctivated [36,45,46]. We deleted RAD53 or CHK1 and exam-
ned the effects in cdc13-1 mrc1 mutants. Deletion of RAD53
equires simultaneous deletion of SML1 to obtain viable
pores. Sml1 is a small protein that inhibits the activity
f ribonucleotide reductase (RNR) which catalyzes the rate-
imiting step of de novo dNTP synthesis [47]. Normally Sml1
s degraded in a Rad53-dependent manner during S phase
48]. We found that removal of RAD53 and SML1 improved
he growth of cdc13-1 mrc1 strains (Fig. 4A). However, dele-
ion of SML1 alone (cdc13-1 mrc1 sml1) also rescued the
rowth defects associated with MRC1 deletion (Fig. 4A). Thus,
e were unable to observe any strong role for Rad53, in
aintaining vitality of cdc13-1 mrc1 mutants, other than in
ig. 3 – Exo1 contributes to the poor growth of cdc13-1 mrc1 and
n Fig. 1. The relevant genotypes are indicated on the left, and stdicated on the left, and strain numbers are shown in
degrading Sml1.We suggest that the reason that deleting Sml1
improves the growth of cdc13-1 mrc1 strains is that increased
ribonucleotide reductase activity may stabilise the replication
forks.
Removal of Chk1, like removal of Rad53, does not rescue
growth of cdc13-1 mrc1 strains, indicating that Chk1 does not
inhibit growth of thesemutants (Fig. 4B). Therefore, we ﬁnd no
evidence that inactivating DNA damage checkpoint pathways
improves growth of cdc13-1 mrc1mutants.
A CHK1 deletion strongly rescues growth of yku70
mrc1 mutants at restrictive temperatures (Fig. 4C) sim-
ilarly to its effect in yku70 mutants [36]. Thus, mrc1
yku70 uncapped telomeres qualitatively behave like yku70
uncapped mutants. The effects of chk1 in yku70 mrc1
and cdc13-1 mrc1 strains are consistent with earlier ﬁndings
showing that the Chk1-dependent pathway ismore important
in yku70mutants [36,45].
yku70 mrc1 strains. Colonies were plated as described
rain numbers are shown in parentheses.
1612 dna repa ir 6 ( 2 0 0 7 ) 1607–1617
Fig. 4 – Differential suppression of cdc13-1 mrc1 and yku70mrc1 growth defects by checkpoint mutations. Colonies were
cateplated as described in Fig. 1. The relevant genotypes are indi
3.5. Mrc1 is not required for the cell cycle arrest after
cdc13-1 uncapping
To directly test whether Mrc1 plays a checkpoint role in
cdc13-1 strains, cdc13-1 strains with additional mutations
were ﬁrst grown at the semi-permissive temperature 27.3 ◦C.
Strains defective in telomere capping (cdc13-1) arrest atmedial
nuclear division before entry to anaphase after 3h at 27.3 ◦C
(Fig. 5A). As expected, when the checkpoint is compromised
in cdc13-1 chk1, cdc13-1 rad9 or cdc13-1 rad53 cells, no
accumulation at medial nuclear division is observed over 9h
(Fig. 5A). In contrast, cdc13-1 and cdc13-1 mrc1 strains rapidly
accumulate at medial nuclear division and within 3h more
than 90% of cells are arrested at this point. Consistent with
these conclusions cell numbers stopped increasing in cdc13-
1 and cdc13-1 mrc1 strains, but continued to increase in the
other strains (Fig. 5B). We conclude that Mrc1 is not required
for the checkpoint response to cdc13-1 dependent telomere
uncapping.
Rad53 and Chk1 are components of parallel checkpoint
pathways that respond to cdc13-1 induced telomere uncapping
[45,46]. It appears that the Rad53 pathway is more important
for arrest of cdc13-1 mrc1 mutants because 80% of cdc13-1
mrc1 chk1 cells have arrested at medial nuclear division
by 7.5h, whereas there is no arrest of cdc13-1 mrc1 rad53
cells.d on the left, and strain numbers are shown in parentheses.
To test the role of Mrc1 in checkpoint control in a sin-
gle cell cycle we combined mrc1 with cdc13-1 cdc15-2 and
bar1 mutations. Over many years we and others have used
these mutations to determine the effects of checkpoint pro-
teins in responding to telomere uncapping [13,39,40,45]. Bar1
encodes a protease that degrades the mating pheromone -
factor. Cells bearing the bar1mutation can efﬁciently arrest in
G1 phase of the cell cycle with low levels of -factor. Cdc15 is
necessary for mitotic exit. At 36 ◦C, cdc13-1 cdc15-2 bar1 con-
trol strains, released from alpha factor arrest, accumulate at
medial nuclear division due to cdc13-1-dependent telomere
uncapping. However, if cells have escaped the G2/M check-
point, like cdc13-1 rad9 cdc15-2 bar1 strains, they arrest at late
nuclear division due to cdc15-2 and they are unable to proceed
to the next cycle. The cdc15-2 dependent cell cycle arrest helps
in two ways, it ensures that DNA damage checkpoint defects
are easily quantiﬁed because cells with checkpoint defects
accumulate at a later stage of the cell cycle and that DNAdam-
age caused by cdc13-1 is not ampliﬁed during new rounds of
DNA replication.
cdc13-1 cdc15-2 bar1 strains with additionalmutations were
arrested with -factor, then released from G1 and transferred
to a non-permissive temperature to induce telomere uncap-
ping and the cell cycle position was monitored. Fig. 5C shows
that in contrast to cdc13-1 rad9 strains cdc13-1 and cdc13-1
mrc1 strains arrest at medial nuclear division with similar
dna repa ir 6 ( 2 0 0 7 ) 1607–1617 1613
Fig. 5 – Mrc1 does not contribute to checkpoint activation after cdc13-1 dependent telomere uncapping. (A and B) 7 cdc13-1
strains, whose genotypes are shown in e, were switched from 23 ◦C to 27.3 ◦C and their cell cycle position and growth were
monitored, as described in Section 2. (C and D) cdc15-2 bar1 strains with additional mutations [DLY2646 (cdc13-1 mrc1),
DLY3071 (cdc13-1 mrc1 exo1), DLY1468 (cdc13-1), DLY1470 (cdc13-1 rad9)] were synchronised with -factor, released from
G1 to non-permissive temperature (36 ◦C) to induce telomere uncapping and cell cycle position was measured, after cells
were ﬁxed in 70% ethanol and stained with DAPI. (E) Genotypes of strains used for the asynchronous cultures demonstrated
in (a and b) are shown. (F) Western blot demonstrating Rad53 phosphorylation in various cdc13-1 strains with the additional
mutations indicated [DLY1108 (cdc13-1 RAD+), DLY1256 (cdc13-1 rad9), DLY2532 (cdc13-1 mrc1), DLY2533 (cdc13-1 mrc1)].
Cultures were grown overnight at 23 ◦C, diluted in the morning and divided in two. While still growing exponentially, the
temperature was raised to 36 ◦C in one of the aliquots and samples were taken 2h later and processed for Western blots.
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pnti-Tubulin was used as a loading control.
inetics at 36 ◦C, supporting the idea that Mrc1 does not play
role in checkpoint activation after cdc13-1 telomere uncap-
ing. Interestingly, cdc13-1 mrc1 exo1 remain arrested at
edial nuclear division (Fig. 5C and D) which contrasts to the
ehaviour of cdc13-1 exo1 that begin to escape arrest during
he 4-h period in analogous experiments [39]. This difference
ost likely reﬂects the fact that cdc13-1 mrc1 exo1mutants
ave more severe telomere capping defect than cdc13-1 exo1
utants and therefore activate a stronger checkpoint signal.
In response to both replication stress and DNA damage,
ctivation of the checkpoint machinery induces phosphoryla-
ion and activation of Rad53 kinase. Therefore, we addressed
he role of Mrc1 in Rad53 phosphorylation after telomere
ncapping. cdc13-1 strains were exposed to 36 ◦C for 2h and
ad53 phosphorylation was measured by Western blot. Rad53
hosphorylation is observed in cdc13-1 mrc1 strains but notin cdc13-1 rad9 mutants (Fig. 5F), conﬁrming a previous
study [23]. We conclude that activation of Rad53 after cdc13-
1 dependent uncapping at non-permissive temperatures is
Rad9-dependent but Mrc1-independent.
3.6. Mrc1 contributes to telomere length regulation
If Mrc1 plays a protective role at telomeres, this predicts that
strains lacking Mrc1 may have short telomeres. Fig. 6A shows
that absence ofMrc1 results in shorter telomeres, compared to
the wild type. However, the telomere length defects of mrc1
mutants are not as severe as in rad50 or yku70mutants, and
thismayhelp explainwhy cdc13-1mrc1 cells growbetter than
cdc13-1 rad50 cells (Supplementary Fig. 1). Our experiment is
consistent with replication proteins having an important role
in telomere length regulation [49–52].
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Fig. 6 – Mrc1 protects telomeres from shortening and inhibits ssDNA generation at uncapped telomeres. (A) Southern blot
where the telomere length of various strains was examined. DNA was extracted from strains grown at 23 ◦C in liquid YEPD.
Strains used were DLY640 (wild type), DLY641 (wild type), DLY2512 (mrc1), DLY2709 (mrc1), DLY1366 (yku70), DLY2584
(yku70) and DLY1091 (rad50). (B) Schematic ﬁgure to show the PDA1 locus on chromosome V. (C) ssDNA measurements in
the single copy locus of cdc15-2 bar1 strains with the additional mutations indicated; DLY2646 (cdc13-1 mrc1), DLY3071
(cdc13-1 mrc1 exo1), DLY1468 (cdc13-1), DLY1470 (cdc13-1 rad9). Samples were taken, during synchronous cultures, at
the indicated time points after cultures were released from G1 arrest and transferred to non-permissive temperatures
(36 ◦C). DNA preparations were assessed by quantitative ampliﬁcation of ssDNA (QAOS) [37] to measure ssDNA on the TG
and AC strand at PDA1 locus. The error bars represent the standard error of the mean calculated from three independent
measurements of each sample.
3.7. Mrc1 protects telomeres from extended ssDNA
accumulation
All our data suggest an important role of Mrc1 in telomere
capping but no role in cell cycle arrest. To directly test the
role of Mrc1 in telomere capping, we measured ssDNA accu-
mulation on the 3′ TG strand, at PDA1, a single copy locus
approximately 30kb away from the right endof chromosomeV
in cdc13-1 strains (Fig. 6B). cdc13-1 strains were synchronised,
as in Fig. 5C and D in order to follow the effects of Mrc1 on
ssDNA accumulation at non-permissive temperatures within
a single cell cycle. We ﬁnd that cdc13-1 mrc1 mutants, like
cdc13-1 rad9 strains, accumulate more 3′ TG ssDNA at PDA1,
30 kb fromtheuncapped telomere, compared to cdc13-1 strains(Fig. 6C) [39]. This shows that Mrc1, like Rad9, protects cdc13-1
mutants from ssDNA production. Consistent with our conclu-
sion, increased ssDNA accumulation, closer to the telomere,
in telomere repeats, was recently reported in cdc13-1 mrc1
and yku70 mrc1 mutants using both in gel and dot blot
analyses [53]. Importantly, ssDNA production is reduced in
cdc13-1 mrc1 exo1 strains in comparison to cdc13-1 mrc1
strains showing that Mrc1 protects uncapped telomeres from
Exo1-dependent nuclease action. This ssDNA data is consis-
tent with our ﬁnding that Exo1 contributes to the poor growth
of cdc13-1 mrc1 and yku70 mrc1 mutants (Fig. 3). Taken
together, we conclude that Mrc1 inhibits accumulation of
Exo1-dependent ssDNA accumulation after telomere uncap-
ping and, by this criterion, contributes to telomere capping.
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. Discussion
ur experiments demonstrate that Mrc1 contributes to the
itality of budding yeast cells with uncapped telomeres.
herefore, Mrc1 behaves differently from many other known
heckpoint proteins such as Chk1, Mec1, Rad9, Rad17, Rad24
r Rad53, deletion of which improves the growth of cdc13-
mutants at semi-permissive temperatures [39,40]. The
ffect of Mrc1 is more similar to that of the MRX complex,
nother checkpoint complex with roles in telomere capping
36,42,54,55]. It seems that it is the role of Mrc1 at the replica-
ion fork that contributes to the vitality of telomere capping
utants, rather than its role in checkpoint activation. Our
ndings are in accordance with recent work that demon-
trated a protective role of Mrc1 in cells with cdc13-1 or yku70
ncapped telomeres or in telomerase deﬁcient cells [53]. Addi-
ionally, our work demonstrates that the growth defects of
dc13-1 mrc1 and yku70 mrc1 mutants and enhanced
sDNA levels of cdc13-1mrc1 strains are suppressedwhen the
uclease encoded by EXO1 is deleted. Therefore, Mrc1 protects
ncapped telomeres from Exo1.
Mrc1 is recruited to the replicationmachinery asDNA repli-
ation initiates and is required for normal rates of replication
ork progression [17,18,22]. The biochemical role of Mrc1 in
eplication fork progression is unclear which makes it difﬁ-
ult to know its precise role in telomere capping. Mrc1 is also
art of a replication-pausing complex formed when replica-
ion is arrested by the S phase poison hydroxyurea (HU), and
equired for replication fork restart after HU. However, this
estart role for Mrc1 is not universal, since Mrc1 plays no role
n replication restart after cells are treated with the alkylating
gent MMS [22].
It is interesting that there is evidence from budding yeast,
ssion yeast and human cells that telomeric sequences con-
ain DNA regions that slow or stall replication forks [15,56,57].
rom this it seems plausible that telomeric DNA may be more
ependent on proteins like Mrc1, which contribute to fork
tability and restart, than other chromosomal regions. That
s because the replication fork struggles to reach the end of
he chromosome inmrc1mutants where a telomere capping
efect is observed.
Numerous studies on budding yeast mutants with DNA
eplication defects have demonstrated interactions between
NA replication and telomere structure. For example both
dc17/pol1 and cdc44/rfc1 (large subunit of replication factor
) mutants affect telomere length [49]. Here we show that
udding yeast mrc1 mutants have short telomeres. In S.
erevisiae, cdc17/pol1mutants, encoding temperature sensitive
NA polymerase , exhibit very long telomeres, high levels
f telomeric ssDNA and elevated recombination at telomeres
50,51]. Interestingly, the B subunit of DNA polymerase  phys-
cally interacts with Stn1, which in turn interacts with Cdc13
10,52]. This shows there is a very direct interaction between
udding yeast telomere capping proteins and the replica-
ion fork machinery, and suggests that telomere capping is
ntimately linked with DNA replication. In this regard it is,
erhaps, relevant that the 5′–3′ exonuclease Exo1 is involved in
enerating single strandedDNAat uncapped telomeres [36,39]
nd in processing stalled replication forks [58] and highlights) 1607–1617 1615
the similarities betweenuncapped telomeres and stalled repli-
cation forks.
cdc13-1 cells maintain a functional telomere cap (low lev-
els of telomeric ssDNA), when released from G1 arrest into
the S phase poison hydroxyurea. HU stalls replication forks
and stops late origins of replication from ﬁring. However,
if the same cdc13-1 cells are permitted to complete DNA
replication, by removing the S phase poison HU, telomere
uncapping occurs and high levels of ssDNA are observed [59].
Therefore, Cdc13-dependent telomere capping may depend
on a coordinated interaction between the chromosome end,
Cdc13/Stn1/Ten1 and the DNA replication fork. Further stud-
ies examining the interactions between telomeric DNA, the
telomere cap and the replication fork will be necessary to bet-
ter understand these interactions.
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